Robbin Mitchell - 22 Dec 2021 Form 4 Insider Report for KOHLS Corp (KSS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Dec 2021, 15:49:24 UTC
Prior SEC filing
13 Dec 2021
Next SEC filing
14 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By Elizabeth McCright, P.O.A.

Key filing fact

Robbin Mitchell filed Form 4 for KOHLS Corp (KSS) on 27 Dec 2021.

Key facts

  • This page summarizes Robbin Mitchell's Form 4 filing for KOHLS Corp (KSS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 27 Dec 2021, 15:49.

Change

  • Previous filing in this sequence was filed on 13 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KSS transaction

Common Stock

Award

Transaction value
Shares
+22
Change %
+0.52%
Price
Shares after
4,287
Date
22 Dec 2021
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Award of additional restricted stock in lieu of a $0.25 per share dividend issued by the Company on all Common Stock, which was payable December 22, 2021. These shares vest on the same schedule as the underlying restricted shares.

Footnote F2

Includes 4,287 unvested shares of restricted stock.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .